✦ LIBER ✦

Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience

✍ Scribed by Jason A. Efstathiou; Daphna Y. Spiegel; William U. Shipley; Niall M. Heney; Donald S. Kaufman; Andrzej Niemierko; John J. Coen; Rafi Y. Skowronski; Jonathan J. Paly; Francis J. McGovern; Anthony L. Zietman

Book ID: 113612596
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 425 KB
Volume: 61
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2011.11.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Jason A. Efstathiou, Daphna Y. Spieg

Re: Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, et al. Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience. Eur Urol 2012;61:705–11

✍ Neeraj Kumar Goyal; Manish Garg; Apul Goel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Reply to Neeraj Kumar Goyal, Manish Garg

Reply to Neeraj Kumar Goyal, Manish Garg, and Apul Goel's Letter to the Editor re: Re: Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, et al. Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience. Eur Urol 2012;61:705–11

✍ Jason A. Efstathiou; William U. Shipley; Anthony L. Zietman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

2018 Selective bladder preservation by c

2018 Selective bladder preservation by combined modality therapy for invasive bladder cancer

✍ L.A. Kachnic; D.S. Kaufman; A.L. Zietman; K.C. Dallow; P.P. Griffin; N.M. Heney; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Selective bladder preservation by combin

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer

✍ W.U Shipley; D.S Kaufman; E Zehr; N.M Heney; S.C Lane; H.K Thakral; A.F Althause 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Opportunities with combined modality the

Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer

✍ Colvett, Kyle T.; Althausen, Alex F.; Bassil, Barbara; Heney, Niall M.; McGovern 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 830 KB

Combined-modality therapy for organ preservation represents an appropriate alternative to radical surgery in the management of several malignant diseases. The standard therapy for muscle-invasive bladder cancer in the United States has been radical cystectomy. Although the sequelae of radical surger

Bladder-sparing, combined-modality appro

Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer : A multi-institutional, long-term experience

✍ Sisto Perdonà; Riccardo Autorino; Rocco Damiano; Marco De Sio; Brunello Morrica; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract ## BACKGROUND. The authors evaluated their long‐term experience with combined‐modality, conservative treatment in patients with muscle‐invasive bladder cancer. ## METHODS. In total, 121 patients with T2, T3, or T4 bladder cancer (mean age, 63 years; ratio of men to women, 3:1) underw